News
An analysis of the timing of adverse event reports has convinced the company that raw material delivered by a vendor was the ...
Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June ...
Former Avanos Medical executive Michael Greiner has left the company. Greiner was CFO and chief transformation officer at the ...
Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...
Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board members think the agency should keep its leading role.
The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...
The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results